Advertisement

Topics

EMA Panel Recommends Budesonide (Jorveza) for Eosinophilic Esophagitis

10:59 EST 10 Nov 2017 | Medscape

The European Medicine Agency's (EMA's) Committee for Medicinal Products for Human Use has recommended marketing authorization for budesonide for the treatment of adults with eosinophilic esophagitis.
International Approvals

Original Article: EMA Panel Recommends Budesonide (Jorveza) for Eosinophilic Esophagitis

NEXT ARTICLE

More From BioPortfolio on "EMA Panel Recommends Budesonide (Jorveza) for Eosinophilic Esophagitis"

Advertisement
Quick Search
Advertisement
Advertisement